drugset / Trial / NCT05312268
Rasburicase Treatment in Chronic Gouty Arthritis
RandomizedCrossoverOpen-labelTreatment
Summary
The study will establish efficacy and safety of rasburicase in chronic gouty arthritis
Timeline
- Start
- 2022-06-15
- Primary completion
- 2024-10-15
- Completion
- 2025-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rasburicase | Protein / enzyme biologic | 1.5 mg | — |